KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Tax Provisions: 2013-2024

Historic Tax Provisions for Pacira BioSciences (PCRX) over the last 12 years, with Dec 2024 value amounting to $36.5 million.

  • Pacira BioSciences' Tax Provisions fell 11.24% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year decrease of 43.07%. This contributed to the annual value of $36.5 million for FY2024, which is 84.61% up from last year.
  • According to the latest figures from FY2024, Pacira BioSciences' Tax Provisions is $36.5 million, which was up 84.61% from $19.7 million recorded in FY2023.
  • Pacira BioSciences' 5-year Tax Provisions high stood at $36.5 million for FY2024, and its period low was -$125.4 million during FY2020.
  • For the 3-year period, Pacira BioSciences' Tax Provisions averaged around $17.9 million, with its median value being $19.7 million (2023).
  • In the last 5 years, Pacira BioSciences' Tax Provisions tumbled by 46,903.73% in 2020 and then soared by 857.42% in 2023.
  • Over the past 5 years, Pacira BioSciences' Tax Provisions (Yearly) stood at -$125.4 million in 2020, then surged by 111.50% to $14.4 million in 2021, then tumbled by 118.07% to -$2.6 million in 2022, then surged by 857.42% to $19.7 million in 2023, then soared by 84.61% to $36.5 million in 2024.